Chlorpheniramine Pediatric Dose Calculator
Use this chlorpheniramine pediatric dose calculator to check child dosing, confirm the right syrup or tablet strength, and keep age restrictions plus sedation cautions visible before you give the dose.
syrup, tablet, and age restriction
Chlorpheniramine dose calculator details for syrup, tablets, and age checks
Chlorpheniramine searches need child syrup or tablet conversion, a clear age restriction reminder, and sedation cautions because it is an older antihistamine.
Formula
mL per dose = prescribed chlorpheniramine mg per dose / product concentration in mg per mL; tablet plans should match the exact tablet strength instead.
Worked example
If a clinician-directed dose is 2 mg and the syrup concentration is 2 mg/5 mL, the measured volume is 5 mL per dose.
Safety checks before using the result
- Check age restriction language on the label before giving a dose.
- Avoid duplicate combination cold products that also contain antihistamines.
- Seek care for breathing trouble, severe drowsiness, confusion, or accidental overdose.
Practical dosing guide
Before you measure the dose
Chlorpheniramine pediatric dose questions usually come down to the child’s age, the exact syrup or tablet strength, and whether sedation or duplicate cold-medicine ingredients make this a poor fit.
- Child dose check
- Start with age, weight, and the exact product strength, commonly 2 mg/5 mL syrup, instead of estimating by teaspoon or by memory.
- Age restrictions
- Younger children need more caution with first-generation antihistamines, especially when the product is being used for cough-and-cold symptoms instead of a clear allergy plan.
- Sedation and school-day use
- Drowsiness is often the practical limit.
Chlorpheniramine pediatric medication summary
Chlorpheniramine (chlorphenamine) is a first-generation antihistamine used in children for allergy symptoms. Use the pediatric dose calculator to check age- and weight-matched dosing, then watch carefully for drowsiness, age restrictions, and duplicate cold-medicine ingredients.
Avoid OTC cough/cold products containing chlorpheniramine in children <2 years; ages 2–5 require clinician-prescribed dosing (0.35 mg/kg/day divided q4–6h). Label maximums: ages 6–11, 2 mg per dose and 12 mg/day; ages 12 and up, 4 mg per dose and 24 mg/day. Use single-ingredient products only.
Dose at bedtime or low-activity periods to minimize school impairment; paradoxical excitation and nightmares can occur in younger children.
Chlorpheniramine indications and common pediatric uses
Chlorpheniramine is a first-generation antihistamine with meaningful sedation and anticholinergic effects, so its pediatric role is usually short-term and nighttime-focused.
Seasonal/perennial allergic rhinitis with persistent nighttime symptoms
Seasonal/perennial allergic rhinitis with persistent nighttime symptoms: Short-course rescue option when non-sedating therapies fail; transition back once symptoms calm.
Viral upper respiratory infection with disruptive nighttime cough/sneezing
Viral upper respiratory infection with disruptive nighttime cough/sneezing: Use alongside supportive care only; avoid in uncontrolled asthma or lower airway disease.
Atopic dermatitis-associated pruritus disrupting sleep
Atopic dermatitis-associated pruritus disrupting sleep: Adjunct to emollients and topical therapy when itch disrupts sleep.
Allergic conjunctivitis adjunct for tearing/itch
Allergic conjunctivitis adjunct for tearing/itch: Use with topical antihistamine drops and trigger avoidance; stop once symptoms improve.
Vestibular migraine-related nausea in adolescents
Vestibular migraine-related nausea in adolescents: Rare specialist-directed adjunct; not a routine pediatric migraine therapy.
Chemotherapy-associated rhinorrhea and tearing (palliative)
Chemotherapy-associated rhinorrhea and tearing (palliative): Specialist-only palliative adjunct for select cases, not a standard outpatient pathway.
How to give Chlorpheniramine
- Guidance for safe chlorpheniramine use (with or without dextromethorphan) in pediatrics.
- Use an oral syringe or calibrated spoon, follow weight-based volume charts, and dose every 6–8 hours as directed—never exceed the labeled maximum.
- Avoid in children under 4 years for cold symptoms; never use in children under 2 years. Maintain a dosing log to prevent overlap with other cold medications.
Chlorpheniramine side effects, contraindications, and interactions
Sedation, dry mouth, and slowed reaction time are common with chlorpheniramine. Less often, children can develop paradoxical agitation, hallucinations, urinary retention, or cardiovascular symptoms that require prompt evaluation.
Common side effects
- Plan schoolwork, sports, and driving around possible drowsiness and delayed reaction time.
- Encourage hydration, saline spray, and humidified air to reduce anticholinergic dryness.
- Seek urgent review for hallucinations, severe agitation, urinary retention, breathing changes, or sustained palpitations.
Safety checks
- Infants and toddlers under 2 years
- Hypersensitivity to chlorpheniramine or dextromethorphan
- Concurrent monoamine oxidase inhibitors or within 14 days of use
- Narrow-angle glaucoma
- Bladder neck obstruction or urinary retention
- Active lower respiratory disease with wheeze or significant secretion burden
Drug interactions
- Review the full medication list with a clinician or pharmacist before combining therapies.
Chlorpheniramine mechanism and clinical pearls
Chlorpheniramine is a first-generation antihistamine that reduces sneezing, rhinorrhea, and itch by blocking H1 receptors. Because it is lipophilic, it also enters the central nervous system and can cause clinically meaningful sedation. Its muscarinic antagonism adds anticholinergic effects such as dry mouth, constipation, and urinary retention. This mechanism profile explains why chlorpheniramine is usually a short-course fallback rather than routine first-line therapy in pediatrics.
Use chlorpheniramine primarily for short bursts of nighttime relief when non-sedating agents fail. Switch back to second-generation antihistamines for daytime control as soon as possible.
FDA warnings highlight serious adverse events in very young children; always confirm ages and document counseling.
Families often combine cough syrups unintentionally. Provide written instructions to avoid stacking antihistamines or dextromethorphan.
Sedation and slowed reaction time can impair learning. Plan dosing schedules around school and extracurricular activities.
Frequently asked questions about Chlorpheniramine
Use the child’s age, weight, and the exact product strength in the calculator instead of estimating by teaspoon. This is especially important with older sedating antihistamines and combination syrups.
It should not be used in infants under 2 years. Ages 2–5 require clinician guidance and close monitoring because of sedation and anticholinergic risks.
Check ingredient lists. If it already contains an antihistamine or dextromethorphan, wait until the dosing interval has passed and contact your clinician for guidance to avoid overdose or duplicate sedating ingredients.
No. Chlorpheniramine can cause marked drowsiness and slow reaction time. Avoid driving, sports, or operating machinery until the effects are known.
If the goal is daily allergy control with less daytime drowsiness, a newer non-sedating antihistamine is often easier for families to use. Use chlorpheniramine more cautiously when sedation would interfere with school, driving, or sports.
Offer extra water, use a humidifier at night, and add fiber-rich foods to reduce constipation. If the child cannot urinate, has severe dry mouth, or abdominal pain, stop the medication and call your clinician.
Avoid layering with other sedating antihistamines (diphenhydramine, doxylamine) or benzodiazepines. For children on ADHD stimulants, chlorpheniramine is generally safe but pseudoephedrine combinations can worsen tachycardia—double-check with the prescriber.
Call Poison Control or go to the ED for hallucinations, trouble breathing, rapid heartbeat, seizures, or if a child under 2 years accidentally ingests the medicine. Bring the bottle so clinicians can confirm the ingredients.
Sources reviewed for Chlorpheniramine
childrenscolorado-chlorpheniramine-2024
aaaai-otc-antihistamines-2020
fda-caution-cough-cold-kids-2024
nationwidechildrens-otc-cough-cold-2023
aad-atopic-itch-2024
aao-allergic-conjunctivitis-2024